Scientists study rare DNA repair diseases to unlock cancer prevention secrets
NCT ID NCT00001813
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 6 times
Summary
This study looked at people with three rare genetic conditions—xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD)—that affect the body's ability to repair DNA. Researchers examined 709 participants to understand how these defects relate to cancer risk and other health problems. The goal was to better understand the role of DNA repair in preventing cancer, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve understanding of how DNA repair prevents cancer, potentially guiding future treatments for these rare diseases.
- What could go wrong
- This is an observational study, not a treatment trial. It aims to gather knowledge, not test a therapy, so direct patient benefits are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCKAYNE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heat-Sensing camera could spot wound infections before they worsen
- AI matches dermatologists in skin cancer diagnosis study
- Electric shocks plus chemo: a new way to fight melanoma?
- New program aims to ease burden on families of kids with rare diseases
- Could a single DNA test solve the mystery of rare brain diseases in kids?
- Scientists track rare DNA repair diseases to learn how they progress